Association between Type of Drinking Water and Upper Gastrointestinal Cancer Incidence in the Linxian General Population

Author:

Yang Huan1,Wang Jian-bing2,Wang Xiao-kun1,Fan Jin-hu1,Qiao You-Lin1

Affiliation:

1. National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College

2. Zhejiang University School of Medicine

Abstract

Abstract Background We aims to explore the association between type of drinking water and risk of upper gastrointestinal (UGI) cancer, including esophageal cancer (EC) and gastric cancer (GC) incidence in the Linxian General Population Nutrition Intervention Trial (NIT) cohort. Methods This study included healthy adults aged 40 to 69 years from the NIT cohort. All subjects were enrolled in April 1986 and followed through to March 2016. Subjects who drank tap water was treated as an exposed group whereas the remainders were considered as a comparison group. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were estimated using the Cox proportional hazard model. Results During the 30-year follow-up, we identified 5463 UGI cancer cases. After adjusting for age at baseline, gender, body mass index, smoking, and alcohol drinking, family history of UGI cancer, education level, nutrition intervention arms, and intakes of fruit and vegetable, the incidence rate of UGI cancer in participants who drank tap water was significantly lower than that in participants who did not drink tap water (HR = 0.88, 95%CI: 0.83–0.94). Comparable association was observed between tap water drinking and EC incidence (HR = 0.86, 95%CI: 0.79–0.94). For EC incidence, an interaction effect was observed for riboflavin/niacin supplements and type of drinking water (Pinteraction=0.03). No association was observed between type of drinking water and GC incidence. Conclusions Drinking tap water was associated with decreased risk of UGI cancer incidence particularly the of EC incidence. Appropriate measures should be taken to improve the quality of drinking water in high-incidence areas of EC. Trial registration The trial is registered with ClinicalTrials.gov (NCT00342654, 21/06/2006), and the trial name is Nutrition Intervention Trials in Linxian Follow-up Study.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3